Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
AXSM Quote, Financials, Valuation and Earnings
Last price:
$112.82
Seasonality move
:
-7.42%
Day range:
$110.76 - $113.50
52-week range:
$72.21 - $139.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.54x
P/B ratio:
103.87x
Volume:
512.3K
Avg. volume:
648.6K
1-year change:
34.03%
Market cap:
$5.5B
Revenue:
$385.7M
EPS (TTM):
-$5.77
Earnings Data
Next earnings date for AXSM
Aug 04
2025
Most recent earnings per share
-$1.22
Beat by $0.13
(May 5/2025)
Consensus Estimate
-$1.35
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AXSM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $161M | -- | -- | -$0.82 | -- |
| 08/04/2025 | Q2 | $139.5M | -- | -- | -$1.05 | -- |
| 05/05/2025 | Q1 | $119.3M | $121.5M | -$1.22 | -$1.35 | $0.13 |
| 02/18/2025 | Q4 | $117.8M | $118.8M | -$1.54 | -$1.04 | -$0.50 |
| 11/12/2024 | Q3 | $98.1M | $104.8M | -$1.34 | -$1.39 | $0.05 |
| 08/05/2024 | Q2 | $86.9M | $87.2M | -$1.67 | -$1.33 | -$0.34 |
| 05/06/2024 | Q1 | $72.9M | $75M | -$1.44 | -$1.22 | -$0.22 |
| 02/20/2024 | Q4 | $69M | $71.5M | -$2.08 | -$1.19 | -$0.89 |
| 11/06/2023 | Q3 | -- | -- | -$1.32 | -$1.19 | -$0.13 |
| 08/07/2023 | Q2 | -- | -- | -$1.54 | -$1.20 | -$0.34 |
| 05/08/2023 | Q1 | -- | -- | -$0.26 | -$0.72 | $0.46 |
| 02/27/2023 | Q4 | -- | -- | -$1.41 | -$1.14 | -$0.27 |
| 11/07/2022 | Q3 | -- | -- | -$1.07 | -$1.10 | $0.03 |
| 08/09/2022 | Q2 | -- | -- | -$1.06 | -$1.12 | $0.06 |
| 05/02/2022 | Q1 | -- | -- | -$1.03 | -$1.02 | -$0.02 |
| 03/01/2022 | Q4 | -- | -- | -$0.90 | -$0.97 | $0.07 |
| 11/08/2021 | Q3 | -- | -- | -$0.93 | -$0.94 | $0.01 |
| 08/09/2021 | Q2 | -- | -- | -$0.86 | -$0.88 | $0.02 |
| 05/10/2021 | Q1 | -- | -- | -$0.78 | -$0.81 | $0.03 |
| 03/01/2021 | Q4 | -- | -- | -$0.78 | -$0.70 | -$0.08 |
| 11/05/2020 | Q3 | -- | -- | -$0.61 | -$0.55 | -$0.06 |
| 08/10/2020 | Q2 | -- | -- | -$0.49 | -$0.61 | $0.12 |
| 05/08/2020 | Q1 | -- | -- | -$0.88 | -$0.66 | -$0.22 |
| 03/12/2020 | Q4 | -- | -- | -$0.71 | -$0.46 | -$0.25 |
| 11/07/2019 | Q3 | -- | -- | -$0.56 | -$0.39 | -$0.17 |
| 08/08/2019 | Q2 | -- | -- | -$0.41 | -$0.32 | -$0.10 |
| 05/09/2019 | Q1 | -- | -- | -$0.32 | -$0.30 | -$0.02 |
| 03/14/2019 | Q4 | -- | -- | -$0.32 | -$0.30 | -$0.02 |
| 11/09/2018 | Q3 | -- | -- | -$0.31 | -- | -- |
| 08/08/2018 | Q2 | -- | -- | -$0.32 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
| 03/07/2018 | Q4 | -- | -- | -$0.31 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.27 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.41 | -- | -- |
| 03/07/2017 | Q4 | -- | -- | -$0.38 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.38 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.36 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.31 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.12 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.26 | -- | -- |
Axsome Therapeutics Earnings Questions
-
How Much did Axsome Therapeutics Generate in Revenue Last Quarter?
Axsome Therapeutics reported $121.5M worth of top line sales in its most recent quarter.
-
Did Axsome Therapeutics Beat Earnings Last Quarter?
Axsome Therapeutics announced earnings per share of -$1.22 which represents a beat of analyst forecast a -$1.35 per share.
-
Is Axsome Therapeutics Profitable?
Axsome Therapeutics reported $111.7M that represents $2.29 per share over the last quarter.
-
What is the Analyst Consensus for Axsome Therapeutics EPS Next Year?
Axsome Therapeutics's earnings are forecast to decrease from -$5.99 per share to -$5.25 per share next year representing a decrease of -35.68%.
-
When is Axsome Therapeutics's Earnings Date?
Axsome Therapeutics's next earnings date is August 4, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 3.9% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is down 0.25% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 3.81% over the past day.
